Literature DB >> 16213498

Inhibition of matrix metalloproteinase-9 by interferons and TGF-beta1 through distinct signalings accounts for reduced monocyte invasiveness.

Juliette Nguyen1, Perrine Knapnougel, Philippe Lesavre, Brigitte Bauvois.   

Abstract

Cytokines may provide signals for regulating human monocyte matrix metalloproteinase-9 (MMP-9) activity. In this study, we investigated the roles of interferons (IFN) type I/II and transforming growth factor-beta1 (TGF-beta1) in MMP-9-mediated invasiveness. MMP-9 antibody and inhibitor, IFNs and TGF-beta1 inhibited monocyte transmigration through Matrigel. IFNs and TGF-beta1 downregulated MMP-9 mRNA, protein and activity levels. The inhibitory action of IFNs was associated with the STAT1/IRF-1 pathway since the JAK inhibitor AG490 blocked STAT1 phosphorylation, IRF-1 synthesis and counteracted the blockade of MMP-9 release. TGF-beta1-mediated MMP-9 inhibition appeared STAT1/IRF-1-independent but reversed by the protein tyrosine kinase inhibitor tyrphostin 25. Our data point out the importance of IFNs and TGF-beta1 in the control of monocyte MMP-9-mediated extravasation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16213498     DOI: 10.1016/j.febslet.2005.09.012

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Aberrant collagenase expression in chronic idiopathic myelofibrosis is related to the stage of disease but not to the JAK2 mutation status.

Authors:  Oliver Bock; Johanne Neuse; Kais Hussein; Kai Brakensiek; Guntram Buesche; Thomas Buhr; Birgitt Wiese; Hans Kreipe
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

2.  Lipopolysaccharide-induced expression of matrix metalloproteinases in human monocytes is suppressed by IFN-gamma via superinduction of ATF-3 and suppression of AP-1.

Authors:  Hao H Ho; Taras T Antoniv; Jong-Dae Ji; Lionel B Ivashkiv
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

3.  Circulating MMP-9 during exercise in humans.

Authors:  E Rullman; K Olsson; D Wågsäter; T Gustafsson
Journal:  Eur J Appl Physiol       Date:  2012-11-17       Impact factor: 3.078

4.  Inhibition of human neutrophil degranulation by transforming growth factor-beta1.

Authors:  L Shen; J M Smith; Z Shen; M Eriksson; C Sentman; C R Wira
Journal:  Clin Exp Immunol       Date:  2007-04-02       Impact factor: 4.330

5.  Differential stress responses among newly received calves: variations in reductant capacity and Hsp gene expression.

Authors:  Harel Eitam; Jacob Vaya; Arieh Brosh; Ala Orlov; Soliman Khatib; Ido Izhaki; Ariel Shabtay
Journal:  Cell Stress Chaperones       Date:  2010-04-18       Impact factor: 3.667

6.  The interferon-gamma-induced GTPase, mGBP-2, inhibits tumor necrosis factor alpha (TNF-alpha) induction of matrix metalloproteinase-9 (MMP-9) by inhibiting NF-kappaB and Rac protein.

Authors:  Sujata Balasubramanian; Meiyun Fan; Angela F Messmer-Blust; Chuan H Yang; Jill A Trendel; Jonathan A Jeyaratnam; Lawrence M Pfeffer; Deborah J Vestal
Journal:  J Biol Chem       Date:  2011-04-18       Impact factor: 5.157

7.  GM-CSF contributes to aortic aneurysms resulting from SMAD3 deficiency.

Authors:  Ping Ye; Wenhao Chen; Jie Wu; Xiaofan Huang; Jun Li; Sihua Wang; Zheng Liu; Guohua Wang; Xiao Yang; Peng Zhang; Qiulun Lv; Jiahong Xia
Journal:  J Clin Invest       Date:  2013-04-15       Impact factor: 14.808

8.  Macrophage secretome from women with HIV-associated neurocognitive disorders.

Authors:  Krystal Colon; Juliana Perez-Laspiur; Raymond Quiles; Yolanda Rodriguez; Valerie Wojna; Scott A Shaffer; John Leszyk; Richard L Skolasky; Loyda M Melendez
Journal:  Proteomics Clin Appl       Date:  2015-11-18       Impact factor: 3.494

9.  Novel STAT binding elements mediate IL-6 regulation of MMP-1 and MMP-3.

Authors:  Samuel J Cutler; James D Doecke; Ibtisam Ghazawi; Jinbo Yang; Lyn R Griffiths; Kevin J Spring; Stephen J Ralph; Albert S Mellick
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

Review 10.  MMP9: A Tough Target for Targeted Therapy for Cancer.

Authors:  Katarzyna Augoff; Anita Hryniewicz-Jankowska; Renata Tabola; Kamilla Stach
Journal:  Cancers (Basel)       Date:  2022-04-06       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.